Gabapentin Premedication and Adenotonsillectomy in Pediatric Patients

• Status: Completed
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The frequent incidence of postoperative vomiting and severe pain in children undergoing adenotonsillectomy, may delay postoperative oral intake and increase the risk of dehydration. Postoperative nausea and vomiting (PONV) is of multi-factorial origin in this group of patients, with a reported incidence ranging from 23% to 73%.

There is growing evidence that the perioperative administration of gabapentinin in adults is beneficial for preoperative anxiolysis, postoperative analgesia, reduction of postoperative nausea and vomiting, and delirium.

Only few studies in literature explored the analgesic effects of preoperative gabapentin as premedication in pediatric population. However, the antiemetic effect of gabapentin in pediatric patients was not systematically investigated before.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Anesthetics; Gabapentin; gamma-Aminobutyric Acid; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Aged (3-12)

• ASA physical status I or II

• Scheduled for adenotonsillectomy surgery in Abu Elrish Al-Mounira Hospital

Exclusion Criteria:

• Patients who have active infection

• Obstructive sleep apnea

• Cognitive impairment

• Abnormal bleeding profile

• Renal or hepatic dysfunction

• History of allergic reaction to study medications or chronic use of anti-consultants will be excluded.